A Cognitive Occupation-Based Programme for People with Multiple Sclerosis: A Study to Test Feasibility and Clinical Outcomes

Occupational Therapy International
Sean Reilly, Sinéad M Hynes

Abstract

Cognitive impairments are common in MS and affect personal, social, and occupational functioning. There is a developing body of evidence highlighting the role of cognitive rehabilitation, but there is still no evidence for a validated holistic approach. The aim of this study was to assess the effectiveness of Cognitive Occupation-Based Programme for People with Multiple Sclerosis (COB-MS) for improving daily life and cognitive impairment. This study used an experimental pretest/posttest design with eight-week follow-up. Participants were recruited from MS networks using convenience sampling. The primary outcome measure was the GAS. Secondary outcomes included the OSA-DLS, CVLT-II, BVMT-R, SDMT, TMT, BRIEF-A, and EMQ-R. Twelve participants were recruited, aged 39-73 years (mean: 55.08; SD: 9.61). There were statistically significant improvements in the GAS (p < .002), CVLT-II: total free recall (p < .000), short delay free recall (p < .018), long delay free recall (p < .008), BVMT-R total recall (p < .000), TMT part B (p < .044), and EMQ-R (p < .006). Except for the BRIEF-A, clinically significant improvements were observed in secondary outcome measures at posttest and follow-up. Limitations include selection bias and subtle pra...Continue Reading

References

Dec 1, 1993·Acta Neurologica Scandinavica·A JønssonE Byskov-Ottosen
Dec 9, 1998·Journal of Clinical and Experimental Neuropsychology·R H Benedict, D J Zgaljardic
Jan 11, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·N B LincolnE D Playford
May 7, 2002·Applied Neuropsychology·D J Zgaljardic, R H Benedict
Dec 1, 1963·Perceptual and Motor Skills·R A CRADDICK, M R STERN
Mar 11, 2004·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Ralph M Reitan, Deborah Wolfson
Jul 9, 2004·Journal of the Neurological Sciences·Alessandra SolariUNKNOWN CRIMS Trial
Mar 1, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Nancy D ChiaravallotiJoseph H Ricker
Apr 29, 2006·Journal of the Neurological Sciences·Maria Pia AmatoEmilio Portaccio
May 25, 2006·Behavioural Neurology·Susan H Pierson, Nathan Griffith
Aug 25, 2007·Annual Review of Clinical Psychology·Barbara A Wilson
Sep 14, 2007·Disability and Rehabilitation·Jane Royle, Nadina B Lincoln
Feb 8, 2008·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Sun Wook LeeGail Fisher
Apr 1, 2008·Archives of Physical Medicine and Rehabilitation·Amanda R O'BrienJohn Deluca
Nov 15, 2008·Lancet Neurology·Nancy D Chiaravalloti, John DeLuca
Jun 18, 2009·Restorative Neurology and Neuroscience·Annamarie VogtIris-Katharina Penner
Aug 5, 2009·Health Education Research·Eynat Shevil, Marcia Finlayson
Sep 29, 2009·Journal of the Neurological Sciences·A D Sadovnick
Dec 5, 2009·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Jared M BruceSharon Lynch
Jul 14, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Frauke FinkHelmut Hildebrandt
Apr 27, 2011·Current Opinion in Neurology·Dawn W Langdon
Aug 3, 2012·Neurocase·H BrissartM Debouverie
Aug 21, 2013·Multiple Sclerosis : Clinical and Laboratory Research·M P AmatoM Trojano
Dec 1, 1968·Community Mental Health Journal·T J Kiresuk, R E Sherman
Feb 17, 2015·Journal of Clinical and Experimental Neuropsychology·Laura M HancockSharon G Lynch

❮ Previous
Next ❯

Citations

Jan 21, 2020·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association
Jul 10, 2020·Scandinavian Journal of Occupational Therapy·Éle Quinn, Sinéad M Hynes
Feb 7, 2021·International Journal of Environmental Research and Public Health·Luis De-Bernardi-OjuelManuela García-de-la-Hera

❮ Previous
Next ❯

Software Mentioned

COB
DLS
OSA
MS
EMQ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.